Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19

A severely immunocompromised patient with MM and COVID19 who received a convalescent plasma product showed SARS-CoV-2 clearance. The convalescent plasma showed humoral immunity against all structural SARS-CoV-2 proteins, which was successfully transferred to the patient.

Detalles Bibliográficos
Autores principales: Luetkens, Tim, Metcalf, Ryan, Planelles, Vicente, Zheng, Yue, Larragoite, Erin T., Spivak, Emily S., Spivak, Adam M., Steinbach, Mary, Blaylock, Robert C., Avila, Stephanie V., Hankey, Kim G., Martins, Thomas B., Slev, Patricia R., Mannuel, Heather D., Sajadi, Mohammad, Rapoport, Aaron P., Atanackovic, Djordje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556131/
https://www.ncbi.nlm.nih.gov/pubmed/33031540
http://dx.doi.org/10.1182/bloodadvances.2020002595
Descripción
Sumario:A severely immunocompromised patient with MM and COVID19 who received a convalescent plasma product showed SARS-CoV-2 clearance. The convalescent plasma showed humoral immunity against all structural SARS-CoV-2 proteins, which was successfully transferred to the patient.

Ejemplares similares